Radiotherapy 50 Gy

RADIATION3 trials

Sponsors

Gustave Roussy, Cancer Campus, Grand Paris, UNICANCER, Lithuanian University of Health Sciences

Conditions

Cancer of the RectumNeoadjuvant Therapy in Rectal Cancer, Radiotherapy, FOLFOXOral CancerOropharynx Cancer

Phase 2

Neoadjuvant Therapy vs Standard Therapy in Locally Advanced Rectal Cancer

RecruitingNCT05378919

Lithuanian University of Health SciencesNeoadjuvant Therapy in Rectal Cancer, Radiotherapy, FOLFOX

Start: 2015-06-01End: 2027-06-01Target: 250Updated: 2022-05-18

Phase 3

Efficacy of Neoadjuvant Folfirinox Regimen in Patients With Resectable Locally Advanced Rectal Cancer

CompletedNCT01804790

UNICANCERCancer of the Rectum

Start: 2012-01-31End: 2023-07-01Updated: 2025-06-12

Unknown Phase

Postoperative Radiotherapy According to Molecular Analysis of Surgical Margins of Oral and Oropharyngeal SCC

Gustave Roussy, Cancer Campus, Grand ParisOral Cancer, Oropharynx Cancer

Start: 2005-10-31End: 2014-06-30Updated: 2012-03-28

Related Papers

Missing data and missed opportunities: Inability to perform secondary analysis of prospective randomized control trials due to missing general anesthesia data.

Journal of Clinical Oncology2025-05-28

Molecular analysis of surgical margins with NGS to assess microscopic residual disease in early oral squamous cell carcinomas.

Journal of Clinical Oncology2024-06-01

Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiation in patients with locally advanced rectal cancer: 7-year results of PRODIGE 23 phase III trial, a UNICANCER GI trial.

Journal of Clinical Oncology2023-06-07104 citations

Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial.

2021-04-13821 citations

Locally advanced rectal adenocarcinoma: Treatment sequences, intensification, and rectal organ preservation

CA A Cancer Journal for Clinicians2021-02-1621 citations

Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiation in patients with locally advanced rectal cancer: Final results of PRODIGE 23 phase III trial, a UNICANCER GI trial.

Journal of Clinical Oncology2020-05-20176 citations